Keywords: imutec, restarts, virulizin, program, corp, shortly, restart

Imutec Restarts Virulizin Program

Article | 08 April 1996

Imutec Corp will shortly restart its clinical trial program for Virulizin for the treatment of advanced Kaposi's sarcoma in patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in